Naruto, Japan

Kazunobu Kurisu

This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazunobu Kurisu. Retrieved from https://idiyas.com/inventor/kazunobu-kurisu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazunobu Kurisu: Innovator in Pharmaceuticals

Introduction

Kazunobu Kurisu is an accomplished inventor based in Naruto, Japan, known for his significant contributions to the pharmaceutical industry. His expertise in developing innovative compounds has led to advancements in therapeutic applications.

Latest Patents

Kurisu holds one notable patent: “Pyrimidine derivatives, method of manufacturing the same, and androgen.” This patent reflects his dedication to discovering new chemical compounds that can be utilized in medicinal applications.

Career Highlights

Currently, Kazunobu Kurisu is associated with Otsuka Pharmaceutical Company, Limited, where he leverages his skills and knowledge to drive innovation in drug development. His commitment to excellence has established him as a respected figure within the company.

Collaborations

Throughout his career, Kurisu has collaborated with talented coworkers, including Hiroshi Kiyokawa and Satoshi Yamada. These partnerships have enriched his research and fostered an environment of shared innovation.

Conclusion

Kazunobu Kurisu's contributions to the field of pharmaceuticals through his inventive spirit and collaborative efforts exemplify the essential role of inventors in advancing medical science. His work not only reflects personal achievement but also illustrates the collective progress within the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…